In addition, tumor cells can evade immune surveillance through epigenetic silencing mediated by the polycomb repressive complex 2 (PRC2), suppression of IFN-γ signaling by double homeobox protein 5 (DUX5), and loss of NLRC5 expression [51]. The gene discussed is IFNG; the disease is neoplasm.